Jiangxi Synergy Pharmaceutical Co Ltd
Jiangxi Synergy Pharmaceutical Co., Ltd. engages in research and development, production, and sales of chemical raw materials and pharmaceutical intermediates in China and internationally. The company offers nervous system drugs, digestive system medications, antipyretic analgesics and non-steroidal anti-inflammatory analgesics, antihypertensive drugs, anticoagulants, hypoglycemic drugs, antidepr… Read more
Market Cap & Net Worth: Jiangxi Synergy Pharmaceutical Co Ltd (300636)
Jiangxi Synergy Pharmaceutical Co Ltd (SHE:300636) has a market capitalization of $464.75 Million (CN¥3.41 Billion) as of March 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #12621 globally and #3147 in its home market, demonstrating a 1.12% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jiangxi Synergy Pharmaceutical Co Ltd's stock price CN¥8.12 by its total outstanding shares 419951495 (419.95 Million).
Jiangxi Synergy Pharmaceutical Co Ltd Market Cap History: 2017 to 2026
Jiangxi Synergy Pharmaceutical Co Ltd's market capitalization history from 2017 to 2026. Data shows growth from $447.24 Million to $464.75 Million (4.87% CAGR).
Jiangxi Synergy Pharmaceutical Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Jiangxi Synergy Pharmaceutical Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.60x
Jiangxi Synergy Pharmaceutical Co Ltd's market cap is 0.60 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
4.28x
Jiangxi Synergy Pharmaceutical Co Ltd's market cap is 4.28 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $447.24 Million | $296.72 Million | $65.46 Million | 1.51x | 6.83x |
| 2018 | $260.75 Million | $267.12 Million | $24.53 Million | 0.98x | 10.63x |
| 2019 | $434.85 Million | $413.06 Million | $48.31 Million | 1.05x | 9.00x |
| 2020 | $529.76 Million | $435.42 Million | $70.05 Million | 1.22x | 7.56x |
| 2021 | $994.78 Million | $592.13 Million | $81.12 Million | 1.68x | 12.26x |
| 2022 | $841.56 Million | $719.91 Million | $100.67 Million | 1.17x | 8.36x |
| 2023 | $600.96 Million | $722.14 Million | $105.98 Million | 0.83x | 5.67x |
| 2024 | $456.17 Million | $758.89 Million | $106.58 Million | 0.60x | 4.28x |
Competitor Companies of 300636 by Market Capitalization
Companies near Jiangxi Synergy Pharmaceutical Co Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Jiangxi Synergy Pharmaceutical Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Jiangxi Synergy Pharmaceutical Co Ltd Historical Marketcap From 2017 to 2026
Between 2017 and today, Jiangxi Synergy Pharmaceutical Co Ltd's market cap moved from $447.24 Million to $ 464.75 Million, with a yearly change of 4.87%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥464.75 Million | +8.12% |
| 2025 | CN¥429.84 Million | -5.77% |
| 2024 | CN¥456.17 Million | -24.09% |
| 2023 | CN¥600.96 Million | -28.59% |
| 2022 | CN¥841.56 Million | -15.40% |
| 2021 | CN¥994.78 Million | +87.78% |
| 2020 | CN¥529.76 Million | +21.83% |
| 2019 | CN¥434.85 Million | +66.77% |
| 2018 | CN¥260.75 Million | -41.70% |
| 2017 | CN¥447.24 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Jiangxi Synergy Pharmaceutical Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $464.75 Million USD |
| MoneyControl | $464.75 Million USD |
| MarketWatch | $464.75 Million USD |
| marketcap.company | $464.75 Million USD |
| Reuters | $464.75 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.